RAC: ASX health stocks with massive returns in past 3 years
Race Oncology Limited (ASX:RAC)
Race Oncology is a precision oncology company, currently involved in exploring the use of a cancer drug called Zantrene® as a new therapy for melanoma and clear cell renal cell carcinoma.
Image source: © 2022 Kalkine Media®
RAC has a market capitalisation of AU$298.51 million, and its share price has surged by nearly 2611% in the last three years.
RAC: ASX health stocks with massive returns in past 3 yearsRace...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.000(0.00%) |
Mkt cap ! $270.9M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.62 | $1.55 | $189.9K | 121.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1316 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 34961 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |